I agree that this site is using cookies. You can find further informations here.
X
Vives, Joaquim
119  results:
OpenAccess-fulltext X
Search for persons X
?
1

A management model in blood, tissue and cell establishments..:

Delgadillo Duarte, Joaquin ; Kerkelä, Erja ; Waters, Allison...
Cytotherapy;25(12).  , 2023
Link: https://hdl.handle.net/1..
 
?
2

Optimized reagents for immunopotency assays on mesenchymal ..:

Torrents, Sílvia ; del Moral, Andrés Escudero ; Codinach, Margarita...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148700/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Preservation of critical quality attributes of mesenchymal ..:

Martorell, Lluís ; López Fernández, Alba ; García Lizarribar, Andrea...
https://doi.org/10.1002/bit.28381.  , 2023
Link: http://hdl.handle.net/24..
 
?
4

Optimized reagents for immunopotency assays on mesenchymal ..:

Torrents, Sílvia ; Escudero del Moral, Andrés ; Codinach, Margarita...
Immunologic Research;71.  , 2023
Link: https://hdl.handle.net/1..
 
?
5

Cell and gene therapy workforce development: the role of th..:

Vives, Joaquim ; Sanchez-Guijo, Fermin ; Gnecchi, Massimiliano.
Cytotherapy;25(10).  , 2023
Link: https://hdl.handle.net/1..
 
?
6

Compliance in Non-Clinical Development of Cell-, Gene-, and..:

Lopez-Navas, Luis ; Torrents, Sílvia ; Sánchez-Pernaute, Rosario.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397649/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

Preclinical Development of a Therapy for Chronic Traumatic ..:

Vives, Joaquim ; Hernández, Joaquim ; Mirabel, Clémentine...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319990/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

Towards the standardization of methods of tissue processing..:

García-Muñoz, Elisabeth ; Vives, Joaquim
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109215/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

Transitioning From Preclinical Evidence to Advanced Therapy..:

Gastelurrutia, Paloma ; Prat Vidal, Cristina ; Vives, Joaquim...
Reproducció del document publicat a: https://doi.org/10.3389/fcvm.2021.604434.  , 2021
Link: http://hdl.handle.net/24..
 
?
10

Transitioning From Preclinical Evidence to Advanced Therapy..:

Gastelurrutia, Paloma ; Prat-Vidal, Cristina ; Vives, Joaquim...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890001/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Wharton's Jelly Mesenchymal Stromal Cells and Derived Extra..:

Muñoz-Domínguez, Noelia ; Roura, Santiago ; Prat-Vidal, Cristina.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471243/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

SARS-CoV-2/COVID-19 pandemic: first wave, impact, response ..:

Garcia-Lopez, Joan ; Delgadillo, Joaquin ; Vilarrodona, Anna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925220/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

A pilot study of circulating levels of TGF-β1 and TGF-β2 as..:

Chaverri, Daniel ; Vivas, Daniel ; Gallardo-Villares, Santiago...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671858/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

First-in-human PeriCord cardiac bioimplant: Scalability and..:

Prat-Vidal, Cristina ; Rodríguez-Gómez, Luciano ; Aylagas, Miriam...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163319/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
15

First-in-human PeriCord cardiac bioimplant: Scalability and..:

Prat Vidal, Cristina ; Rodríguez Gomez, Luciano ; Aylagas, Miriam...
Reproducció del document publicat a: https://doi.org/10.1016/j.ebiom.2020.102729.  , 2020
Link: http://hdl.handle.net/24..
 
1-15